Company: BIAF
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023405
Chunk: 52

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 52
---

30, 2025, the end of the period covered by this Quarterly Report, our Chief Executive Officer and Chief Financial Officer evaluated the
effectiveness of our “disclosure controls and procedures,” as defined in Rule 13a-15(e) under the Exchange Act. The Chief
Executive Officer and Chief Financial Officer assessed the effectiveness of our disclosure controls and procedures as of September 30,
2025. Based on their assessment, they have concluded that as of September 30, 2025, our disclosure controls and procedures are effective.

Changes
in Internal Control over Financial Reporting

There
were no changes in our internal controls (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) over financial reporting
during the three months ended September 30, 2025, the period covered by this Quarterly Report, that could materially affect, or are reasonably
likely to materially affect, our internal control over financial reporting.

27

PART
II OTHER INFORMATION

ITEM
1. LEGAL PROCEEDINGS.

From
time to time, we are involved in various disputes and litigation matters that arise in the ordinary course of business. To date, we have
had no material pending legal proceedings, and we are not engaged in any legal proceedings that are expected, individually or in the
aggregate, to have a material adverse impact on our financial position or results of operations.

ITEM
1A. RISK FACTORS.

In
addition to other information set forth in this Quarterly Report, you should carefully consider the “Risk Factors” discussed
in the 2024 Form 10-K for a discussion of important factors that could cause actual results to differ materially from the results described
in or implied by the forward-looking statements contained in this Quarterly Report. Additional risks and uncertainties not currently
known to us or that we currently deem to be immaterial might materially adversely affect our actual business, financial condition, and
operating results. The following information updates and should be read in conjunction with the information disclosed in Part I, Item
1A, “Risk Factors,” contained in our 2024 Form 10-K. Except as disclosed below, there have been no material changes from
the risk factors disclosed in our 2024 Form 10-K.

Risks
Related to Our Financial Position

Our
business plan relies upon our ability to obtain additional sources of capital and financing. If the amount of capital we are able to
raise from financing activities, together with our revenues